{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:22:31Z","timestamp":1761060151243,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12931-016-0387-7","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T21:09:07Z","timestamp":1466197747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effects of tiotropium\u2009+\u2009olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO\u00ae studies"],"prefix":"10.1186","volume":"17","author":[{"given":"Dave","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Gaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Bjermer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Gr\u00f6nke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Vo\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary T.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,18]]},"reference":[{"key":"387_CR1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2016. http:\/\/www.goldcopd.org\/ . Accessed 6 Jun 2016."},{"key":"387_CR2","unstructured":"National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16\u00a0s: diagnosis and management. Clinical guideline. NICE guidelines [CG101]. http:\/\/www.nice.org.uk\/guidance\/cg101\/resources\/chronic-obstructive-pulmonary-disease-in-over-16s-diagnosis-and-management-35109323931589 . Accessed 6 Jun 2015."},{"key":"387_CR3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","volume":"19","author":"R Casaburi","year":"2002","unstructured":"Casaburi R, Mahler DA, Jones PW, Wanner A, San Pedro G, ZuWallack RL, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002;19:217\u201324.","journal-title":"Eur Respir J"},{"key":"387_CR4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.04.00116004","volume":"23","author":"DE O\u2019Donnell","year":"2004","unstructured":"O\u2019Donnell DE, Fl\u00fcge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23:832\u201340.","journal-title":"Eur Respir J"},{"key":"387_CR5","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1378\/chest.128.3.1168","volume":"128","author":"F Maltais","year":"2005","unstructured":"Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba FC, Richter K, et al. Improvements in symptom-limited exercise performance over 8\u00a0h with once-daily tiotropium in patients with COPD. Chest. 2005;128:1168\u201378.","journal-title":"Chest"},{"key":"387_CR6","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","volume":"359","author":"DP Tashkin","year":"2008","unstructured":"Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543\u201354.","journal-title":"N Engl J Med"},{"key":"387_CR7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.rmed.2010.06.004","volume":"104","author":"ED Bateman","year":"2010","unstructured":"Bateman ED, Tashkin D, Siafakas N, Dahl R, Towse L, Massey D, et al. A one-year trial of tiotropium Respimat\u00ae plus usual therapy in COPD patients. Respir Med. 2010;104:1460\u201372.","journal-title":"Respir Med"},{"key":"387_CR8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4187\/respcare.00852","volume":"56","author":"AM Yohannes","year":"2011","unstructured":"Yohannes AM, Willgoss TG, Vestbo J. Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes. Respir Care. 2011;56:477\u201387.","journal-title":"Respir Care"},{"key":"387_CR9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1008378","volume":"364","author":"C Vogelmeier","year":"2011","unstructured":"Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van M\u00f6lken MPMH, Beeh KM, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med. 2011;364:1093\u2013103.","journal-title":"N Engl J Med"},{"key":"387_CR10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2147\/COPD.S61717","volume":"9","author":"GT Ferguson","year":"2014","unstructured":"Ferguson GT, Feldman GJ, Hofbauer P, Hamilton A, Allen L, Korducki L, et al. Efficacy and safety of olodaterol once daily delivered via Respimat\u00ae in patients with GOLD 2\u20134 COPD: results from two replicate 48-week studies. Int J Chron Obstruct Pulmon Dis. 2014;9:629\u201345.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"387_CR11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/COPD.S62502","volume":"9","author":"A Koch","year":"2014","unstructured":"Koch A, Pizzichini E, Hamilton A, Hart L, Korducki L, De Salvo MC, et al. Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat\u00ae versus placebo and formoterol twice daily in patients with GOLD 2\u20134 COPD: results from two replicate 48-week studies. Int J Chron Obstruct Pulmon Dis. 2014;9:697\u2013714.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"387_CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/2193-1801-3-419","volume":"3","author":"GJ Feldman","year":"2014","unstructured":"Feldman GJ, Bernstein JA, Hamilton A, Nivens MC, Korducki L, LaForce C. The 24-h FEV1 time profile of olodaterol once daily via Respimat\u00ae and formoterol twice daily via Aerolizer\u00ae in patients with GOLD 2\u20134 COPD: results from two 6-week crossover studies. Springerplus. 2014;3:419.","journal-title":"Springerplus"},{"key":"387_CR13","first-page":"196","volume":"4","author":"P Lange","year":"2014","unstructured":"Lange P, Aumann J-L, Hamilton A, Tetzlaff K, Ting N, Derom E. The 24\u00a0hour lung function time profile of olodaterol once daily versus placebo and tiotropium in patients with moderate to very severe chronic obstructive pulmonary disease. J Pulm Respir Med. 2014;4:196.","journal-title":"J Pulm Respir Med"},{"key":"387_CR14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1183\/09031936.00136014","volume":"45","author":"R Buhl","year":"2015","unstructured":"Buhl R, Maltais F, Abrahams R, Bjermer L, Derom E, Ferguson G, et al. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2\u20134). Eur Respir J. 2015;45:969\u201379.","journal-title":"Eur Respir J"},{"key":"387_CR15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1586\/17512433.2015.1075389","volume":"8","author":"M Cazzola","year":"2015","unstructured":"Cazzola M, Rogliani P, Ora J, Matera MG. Olodaterol\u2009+\u2009tiotropium bromide for the treatment of chronic obstructive pulmonary disease. Expert Rev Clin Pharmacol. 2015;8:529\u201339.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"387_CR16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.rmed.2015.08.002","volume":"109","author":"D Singh","year":"2015","unstructured":"Singh D, Ferguson GT, Bolitschek J, Gr\u00f6nke L, Hallmann C, Bennett N, et al. Tiotropium\u2009+\u2009olodaterol shows clinically meaningful improvements in quality of life. Respir Med. 2015;109:1312\u20139.","journal-title":"Respir Med"},{"key":"387_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pupt.2015.04.002","volume":"32","author":"K-M Beeh","year":"2015","unstructured":"Beeh K-M, Westerman J, Kirsten A-M, H\u00e9bert J, Gr\u00f6nke L, Hamilton A, et al. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2015;32:53\u20139.","journal-title":"Pulm Pharmacol Ther"},{"key":"387_CR18","doi-asserted-by":"crossref","unstructured":"Beeh K-M, Derom E, Echave-Sustaeta J, Gr\u00f6nke L, Hamilton A, Zhai D, et al. The lung function profile of once-daily tiotropium and olodaterol via Respimat\u00ae is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler\u00ae (ENERGITO\u00ae study). Int J Chron Obstruct Pulmon Dis. 2016;11:193\u2013205.","DOI":"10.2147\/COPD.S95055"},{"key":"387_CR19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12325-015-0218-0","volume":"32","author":"GT Ferguson","year":"2015","unstructured":"Ferguson GT, Fle\u017ear M, Korn S, Korducki L, Gr\u00f6nke L, Abrahams R, et al. Efficacy of tiotropium\u2009+\u2009olodaterol in patients with chronic obstructive pulmonary disease by initial disease severity and treatment intensity: a post hoc analysis. Adv Ther. 2015;32:523\u201336.","journal-title":"Adv Ther"},{"key":"387_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/COPD.S27480","volume":"7","author":"C Tantucci","year":"2012","unstructured":"Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"387_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3810\/pgm.2014.09.2808","volume":"126","author":"DE O\u2019Donnell","year":"2014","unstructured":"O\u2019Donnell DE, Gebke KB. Examining the role of activity, exercise, and pharmacology in mild COPD. Postgrad Med. 2014;126:135\u201345.","journal-title":"Postgrad Med"},{"key":"387_CR22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/ijcp.12522","volume":"69","author":"T Welte","year":"2015","unstructured":"Welte T, Vogelmeier C, Papi A. COPD: early diagnosis and treatment to slow disease progression. Int J Clin Pract. 2015;69:336\u201349.","journal-title":"Int J Clin Pract"},{"key":"387_CR23","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(09)61298-8","volume":"374","author":"M Decramer","year":"2009","unstructured":"Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009;374:1171\u20138.","journal-title":"Lancet"},{"key":"387_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1465-9921-12-161","volume":"12","author":"PW Jones","year":"2011","unstructured":"Jones PW, Donohue JF, Nedelman J, Pascoe S, Pinault G, Lassen C. Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis. Respir Res. 2011;12:161.","journal-title":"Respir Res"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-016-0387-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:36:49Z","timestamp":1498307809000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-016-0387-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,18]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1186\/s12931-016-0387-7","relation":{},"ISSN":["1465-993X"],"issn-type":[{"type":"electronic","value":"1465-993X"}],"subject":[],"published":{"date-parts":[[2016,6,18]]},"article-number":"73"}}